Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2025-12-26 @ 11:48 AM
NCT ID:
NCT00338416
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed diagnosis of non-myeloid malignancy and receiving chemotherapy
* Baseline Hb of \<= 11 g/dL
* Planned chemotherapy for a minimum of 15 weeks to be administered every 3 weeks
* Female patients with reproductive potential must have a negative serum pregnancy test at screening.
Exclusion Criteria:
* No uncontrolled hypertension or recent history (within 6 months) of uncontrolled cardiac arrhythmias
* No pulmonary embolism
* or thrombosis
* No transfusion of white blood cells or packed red blood cells within 28 days of Epoetin alfa treatment
* No prior treatment with Epoetin alfa or any other erythropoetic agent within the previous three months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT00338416
Study Brief:
Protocol Section:
NCT00338416